Pages that link to "Q34104267"
Jump to navigation
Jump to search
The following pages link to The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals (Q34104267):
Displaying 50 items.
- Durable cytotoxic immune responses against gp120 elicited by recombinant SV40 vectors encoding HIV-1 gp120 +/- IL-15 (Q24792056) (← links)
- CD8+ T lymphocyte responses target functionally important regions of Protease and Integrase in HIV-1 infected subjects (Q24798701) (← links)
- HIV Genome-Wide Protein Associations: a Review of 30 Years of Research (Q26746070) (← links)
- Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses (Q27472844) (← links)
- Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection (Q28480902) (← links)
- Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis (Q30312212) (← links)
- Infectious simian/human immunodeficiency virus with human immunodeficiency virus type 1 subtype C from an African isolate: rhesus macaque model. (Q30329167) (← links)
- Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience. (Q30356937) (← links)
- HIV-1 Tat-based vaccines: an overview and perspectives in the field of HIV/AIDS vaccine development. (Q30381447) (← links)
- Limited nucleotide changes in the Rev response element (RRE) during HIV-1 infection alter overall Rev-RRE activity and Rev multimerization (Q30414086) (← links)
- Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection (Q30830619) (← links)
- Human immunodeficiency virus-specific CD8(+) T cells in human breast milk (Q31093697) (← links)
- Optimized determination of T cell epitope responses (Q31133720) (← links)
- In vitro priming recapitulates in vivo HIV-1 specific T cell responses, revealing rapid loss of virus reactive CD4 T cells in acute HIV-1 infection (Q33402486) (← links)
- Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles (Q33842771) (← links)
- Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design (Q33845527) (← links)
- Structural and regulatory diversity shape HLA-C protein expression levels (Q33851012) (← links)
- Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes (Q33930290) (← links)
- The infiltration kinetics of simian immunodeficiency virus-specific T cells drawn to sites of high antigenic stimulation determines local in vivo viral escape. (Q33949260) (← links)
- Rapid recruitment of virus-specific CD8 T cells restructures immunodominance during protective secondary responses (Q34045631) (← links)
- Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution (Q34092644) (← links)
- Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C. (Q34348269) (← links)
- Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection (Q34358162) (← links)
- Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation (Q34362699) (← links)
- Rational development of prophylactic HIV vaccines based on structural and regulatory proteins (Q34416398) (← links)
- Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. (Q34468117) (← links)
- Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine. (Q34488930) (← links)
- Autologous HIV-1 clade-B Nef peptides elicit increased frequency, breadth and function of CD8+ T-cells compared to consensus peptides (Q34490157) (← links)
- HIV-1 Tat vaccines (Q34556390) (← links)
- The advantage of early recognition of HIV-infected cells by cytotoxic T-lymphocytes (Q34619970) (← links)
- The grafting of universal T-helper epitopes enhances immunogenicity of HIV-1 Tat concurrently improving its safety profile (Q34756847) (← links)
- HIV: current opinion in escapology (Q34772244) (← links)
- HIV-1 vaccines: the search continues (Q34876150) (← links)
- Hide, shield and strike back: how HIV-infected cells avoid immune eradication (Q35058535) (← links)
- HIV immunology better understood and vaccination attempts started: Overview (Q35108702) (← links)
- Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences (Q35149407) (← links)
- Rev variation during persistent lentivirus infection (Q35275897) (← links)
- Naturally arising point mutations in non-essential domains of equine infectious anemia virus Rev alter Rev-dependent nuclear-export activity. (Q35586355) (← links)
- Poxvirus vaccines for cancer and HIV therapy (Q35753546) (← links)
- Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity (Q35761152) (← links)
- Definition of the viral targets of protective HIV-1-specific T cell responses (Q35800157) (← links)
- Effect of therapeutic HIV recombinant poxvirus vaccines on the size of the resting CD4+ T-cell latent HIV reservoir (Q35857687) (← links)
- A single amino acid difference within the alpha-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of Gag and Rev epitopes by equine infectious anemia virus-specific CTL. (Q35929560) (← links)
- Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate (Q36141610) (← links)
- Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames (Q36399462) (← links)
- Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome (Q36474235) (← links)
- Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development (Q36600351) (← links)
- Problems and emerging approaches in HIV/AIDS vaccine development (Q36758574) (← links)
- tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection. (Q36827396) (← links)
- Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection (Q36961218) (← links)